• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Import Refusal Report

  • Print
  • Share
  • E-mail
-

Refusal Actions by FDA as Recorded in OASIS

for 61-Human and Animal Drugs


Entry/doc/line/sfx Refusal Date Product
Code
Manufacturer
FEI
Manufacturer
Name
Manufacturer
Country/Area
AEK-7070154-1/1/1 02-Nov-2005 61ACL06 3005374870 Coen Pomarat Ltd India
 
112-8013606-9/1/1 13-Nov-2005 61BCP02 3004442378 Schering Deutschland Gmbh Germany
 
AEK-6683569-1/3/1 22-Nov-2005 61DAA99 3005387722 Who No Taiwan
 
112-8660821-1/1/1 08-Nov-2005 61ECA99 3003621956 United Laboratories Inc Philippines
 
112-8660821-1/1/2 08-Nov-2005 61ECA99 3003621956 United Laboratories Inc Philippines
 
112-8660821-1/2/1 08-Nov-2005 61ECA99 1000197265 Glaxo Operations Uk Limited United Kingdom
 
112-8700509-4/2/1 14-Nov-2005 61ECQ99 3002945792 Interphil Lab Inc Philippines
 
112-8700509-4/2/2 14-Nov-2005 61ECQ99 3003621956 United Laboratories Inc Philippines
 
112-8251071-7/1/1 22-Nov-2005 61ECQ99 3003887825 Everest De Cargo Nepal
 
112-8402320-6/1/1 30-Nov-2005 61EDQ04 3005456871 Ban-M Fotopoulos Canada
 
112-8302608-5/1/3 25-Nov-2005 61FCA59 3003587477 Lab Pierre Fabre Medicaments France
 
XXX-0129623-6/1/4 01-Nov-2005 61FDY54 3004599659 Cipan Portugal
 
112-7904555-2/1/1 03-Nov-2005 61FPZ34 3005125003 Beijing Institute Of Technology China
 
XXX-0131134-0/1/7 03-Nov-2005 61GDC85 3001669073 UNKNOWN Costa Rica
 
820-4381516-4/2/1 07-Nov-2005 61GJS59 3002807920 Pharmaceutical Works Polpharma S.A. Poland
 
820-4381516-4/1/1 07-Nov-2005 61GJS59 3002807920 Pharmaceutical Works Polpharma S.A. Poland
 
820-4381516-4/2/2 07-Nov-2005 61GJS59 3002807920 Pharmaceutical Works Polpharma S.A. Poland
 
820-4382479-4/1/1 07-Nov-2005 61GJS59 3002807920 Pharmaceutical Works Polpharma S.A. Poland
 
820-4370645-4/1/1 07-Nov-2005 61GJS59 3002807920 Pharmaceutical Works Polpharma S.A. Poland
 
112-8756357-1/1/1 03-Nov-2005 61HBC24 3003817683 Aventis Pharma Switzerland
 
112-8756357-1/1/2 03-Nov-2005 61HBC24 3003817683 Aventis Pharma Switzerland
 
XXX-0130033-5/1/3 01-Nov-2005 61HDB43 3003641053 Aventis Pharma SA Guatemala
 
J49-0355377-5/2/5 09-Nov-2005 61HOL05 3004965837 Lamarvi, S. A. Spain
 
J49-0355377-5/2/9 09-Nov-2005 61HOL05 3004965837 Lamarvi, S. A. Spain
 
J49-0355377-5/3/6 09-Nov-2005 61HOL05 3004965837 Lamarvi, S. A. Spain
 
112-8205875-8/1/3 22-Nov-2005 61JBC12 1000194719 Ranbaxy Laboratories Limited India
 
112-7970588-2/1/1 02-Nov-2005 61JCA08 3002949479 Pfizer Laboratories (Pty) Ltd. South Africa
 
AEK-7071199-5/2/2 08-Nov-2005 61JCA12 3005383221 Saleem Brwani Pakistan
 
112-8785967-2/1/1 04-Nov-2005 61JCA14 3004758118 Merck & Co Inc United States
 
AEK-7071199-5/2/1 08-Nov-2005 61JCA14 3005383221 Saleem Brwani Pakistan
 
XXX-0130590-4/1/2 01-Nov-2005 61JCB08 3003615527 Parke Davis United States
 
112-8029397-7/1/1 16-Nov-2005 61JDB08 2416101 Pfizer Inc. United States
 
XXX-0132210-7/3/1/G 07-Nov-2005 61JRA08 3004561514 Minit Drugs Ltd. Canada
 
112-8219597-2/1/1 25-Nov-2005 61LCB99 3002989060 Procaps S.A. Colombia
 
AEK-7067484-7/1/1 18-Nov-2005 61MCA06 3005348480 Bank Of India India
 
AEK-7071310-8/1/1 25-Nov-2005 61MCA42 3005384240 Uni Wien Sprachwissenschaften Austria
 
112-8106924-4/1/1 17-Nov-2005 61MCA99 1000390471 Pfizer Gmbh Germany
 
112-8183608-9/1/1 16-Nov-2005 61MCK99 3005428157 Pharmerie Chuq-Hotel Dieude Qc Canada
 
XXX-0129271-4/1/18 01-Nov-2005 61MDF41 1000541207 R P Sherer United States
 
AEK-6683563-4/1/1 22-Nov-2005 61NCA11 3005387896 Mandaconsult Ag Switzerland
 
AEK-7072983-1/1/1 03-Nov-2005 61NCA99 3005398183 Asriyants S Uzbekistan
 
AEK-7072983-1/1/2 03-Nov-2005 61NCP99 3005398183 Asriyants S Uzbekistan
 
XXX-0129271-4/1/9 01-Nov-2005 61NDB05 1035048 GlaxoSmithKline United States
 
310-9348835-6/1/1 25-Nov-2005 61NDB76 3005387951 Henry Dib Lebanon
 
XXX-0129271-4/1/15 01-Nov-2005 61NDL66 3003934746 Teva Pharmaceutical Usa F United States
 
112-8205875-8/1/1 22-Nov-2005 61PBC26 3004872389 Franco-Indai India
 
112-8205875-8/1/2 22-Nov-2005 61PBC26 1000657069 Ipca Laboratories India
 
112-8205875-8/1/8 22-Nov-2005 61PBC26 3004448945 Aventis Pharma Ltd India
 
AEK-7067090-2/1/1 03-Nov-2005 61PBF99 3003507632 Gautam Global Also DBA Botanika India
 
112-7938416-7/2/5 01-Nov-2005 61PCA09 3003255171 Usv Limited India
 
112-8292508-9/1/1 25-Nov-2005 61PCA26 3003699941 Cipla Ltd India
 
112-7938416-7/2/2 01-Nov-2005 61PCA55 3003255171 Usv Limited India
 
112-8790171-4/1/2 01-Nov-2005 61PCC09 3003817485 Pfizer, Inc. Philippines
 
112-7902990-3/1/1 18-Nov-2005 61PDB55 3003621956 United Laboratories Inc Philippines
 
112-7902990-3/4/1 18-Nov-2005 61PDB99 3004055168 Les Laboratories Servier Industrie France
 
AEK-7073985-5/1/1 18-Nov-2005 61PDB99 3004214636 Cipla Ltd. India
 
XXX-0129271-4/1/20 01-Nov-2005 61PDC11 3004126471 Novopharm Limited Canada
 
AEK-7071199-5/1/2 08-Nov-2005 61PDP23 3005383221 Saleem Brwani Pakistan
 
XXX-0132210-7/3/1/B 07-Nov-2005 61PRA55 3004561514 Minit Drugs Ltd. Canada
 
AEK-7070691-2/1/1 08-Nov-2005 61TBH99 3005266617 Foyo Herb China
 
XXX-0129271-4/1/4 01-Nov-2005 61TDK17 2024830 Watson Laboratories Inc United States
 
112-8103141-8/2/1 22-Nov-2005 61WBB04 3005417701 Lab Germany
 
112-8770506-5/1/1 04-Nov-2005 61WCB52 3001743983 Novartis Farmaceutica S.A. De C.V. Mexico
 
112-8010995-9/2/1 01-Nov-2005 61WCJ44 3004879799 Roemmers Sa Dominican Republic
 
112-8013606-9/1/2 13-Nov-2005 61WCP45 3004442378 Schering Deutschland Gmbh Germany
 
XXX-0129271-4/1/5 01-Nov-2005 61WDJ48 1628114 DPT Laboratories, Ltd United States
 
U16-5208912-3/1/5 09-Nov-2005 61XBY99 3004079821 Heritage Brands United States
 
112-7938149-4/1/2 02-Nov-2005 61XCA05 3005397084 Laboratories Axioma Colombia
 
XXX-0131134-0/1/5 03-Nov-2005 61XDC45 3001027464 UNKNOWN Guatemala
 
-
-